MEMOTEXT’s omni-channel, evidence-based platform for digital engagement and digital therapeutics enables tailored adherence, care-coordination and indication specific support programs. Co-create, validate and commercialize with MEMOTEXT or choose from a library of pre-validated, peer-reviewed solutions.. Value-based, data-driven, personalized interventions improve outcomes for, clinicians, payors, pharma and patients alike. Leveraging core capabilities in data-driven targeted communications (using multiple modalities such as SMS, IVR, web/mobile apps and voice-assistants), MEMOTEXT has been shown to improve treatment adherence, care-coordination and health outcomes in mental health, chronic and specialty disease management.

MEMOTEXT Corporation Logo



Event details

Date: June 10 - 17, 2021

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


30 in total